« Back to Record
Jerusalem, G., Fasolo, A., Diéras, V., Cardoso, F., Bergh, J., Vittori, L., Zhang, Y., Massacesi, C., Sahmoud, T., & Gianni, L. (2011). Phase i trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer. Breast cancer research and treatment, 125(2), 447-455. doi:10.1007/s10549-010-1260-x
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/169287



